Aug 12, 2026 04:02PM
Aug 10, 2026 08:36AM
Aug 10, 2026 08:32AM
Aug 7, 2026 07:30AM
Aug 5, 2026 07:30AM
Jul 27, 2026 06:32AM
Jul 27, 2026 06:32AM Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026
Jul 14, 2026 07:02AM
Jul 3, 2026 07:30AM
Jun 11, 2026 08:03AM
Jun 11, 2026 08:02AM
Jun 5, 2026 07:30AM
Jun 3, 2026 06:55AM
Jun 3, 2026 06:53AM Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy
Jun 2, 2026 08:33AM
Jun 2, 2026 08:32AM
May 26, 2026 06:02AM
May 26, 2026 06:02AM
May 19, 2026 04:02PM
May 12, 2026 04:02PM
May 12, 2026 09:40AM Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress
May 12, 2026 09:40AM
May 6, 2026 07:30AM
May 5, 2026 07:30AM
May 4, 2026 07:30AM
Apr 24, 2026 08:00AM
Apr 17, 2026 06:00AM
Apr 17, 2026 06:00AM Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
Apr 9, 2026 07:30AM
Apr 3, 2026 07:30AM
Mar 6, 2026 07:30AM
Mar 5, 2026 06:31AM
Feb 26, 2026 07:30AM
Feb 25, 2026 07:30AM
Feb 6, 2026 07:30AM Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 12, 2026 04:07AM
Jan 11, 2026 05:00PM
Jan 5, 2026 07:30AM
Dec 8, 2025 10:30AM
Dec 8, 2025 10:30AM
Dec 3, 2025 08:32AM
Dec 2, 2025 08:02AM Kura receives $135 million milestone payment from Kyowa Kirin
Dec 2, 2025 08:02AM
Nov 25, 2025 05:19PM
Nov 25, 2025 05:16PM
Nov 20, 2025 04:02AM
Nov 13, 2025 10:51AM
Nov 13, 2025 10:51AM
Nov 13, 2025 10:15AM Kura Oncology receives FDA approval for blood cancer drug
Nov 4, 2025 06:31AM

328,337 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All